矢状窦旁/大脑镰旁脑膜瘤切除术后上矢状窦血栓形成的抗凝治疗作用
单中心回顾性分析2005至2020年266例矢状窦旁/大脑镰旁脑膜瘤手术患者,15例(5.6%)出现术后上矢状窦血栓,其中5例(1.9%)有症状、2例(0.8%)接受抗凝;15例均未发生脑血管并发症,双变量分析中术后其他并发症与上矢状窦血栓显著相关(p=0.015),多变量分析控制年龄、性别和肿瘤沿上矢状窦解剖位置后该关联不再显著(OR=2.15,p=0.16)。作者认为保守治疗可能是可行的治疗策略,并指出需进一步研究以更好地预测该不良结局。
要点
- 266例矢状窦旁/大脑镰旁脑膜瘤手术患者中,15例(5.6%)发生术后上矢状窦血栓,5例(1.9%)有症状,2例(0.8%)有症状者接受抗凝。
- 15例上矢状窦血栓患者经观察或抗凝治疗后均未发生脑血管并发症。
- 双变量分析中术后其他并发症与上矢状窦血栓显著相关(p=0.015),多变量分析控制年龄、性别和肿瘤沿上矢状窦解剖位置后关联不再显著(OR=2.15,p=0.16)。
核心结论
- 作者单中心研究提示,保守治疗可能是上矢状窦血栓患者可行的治疗策略,并指出需进一步研究以更好地预测该不良结局。
研究设计与样本
- 单中心回顾性分析2005至2020年266例矢状窦旁/大脑镰旁脑膜瘤手术患者,采用Mann-Whitney U检验和Fisher精确检验进行双变量分析,采用逻辑回归模型进行多变量分析,考察的抗凝药物包括阿司匹林、华法林、肝素、阿哌沙班、利伐沙班和其他新型口服抗凝药(NOACs)。
主要发现
- 患者队列多数为女性(67.3%),平均年龄(±标准差)为58.82±13.04岁。
- 15例(5.6%)患者发生术后上矢状窦血栓,5例(1.9%)有症状,2例(0.8%)有症状患者接受抗凝治疗。
- 15例上矢状窦血栓患者经观察或抗凝治疗无症状性上矢状窦血栓后均未发生脑血管并发症。
- 术后其他并发症发生率与上矢状窦血栓在双变量分析中显著相关(p=0.015),多变量分析控制患者年龄、性别和肿瘤沿上矢状窦解剖位置后该关联不再显著(OR=2.15,p=0.16)。
关键数值与推荐
- 有症状的上矢状窦血栓定义为影像学可见的血栓并伴有新发头痛、癫痫发作、意识改变或神经功能缺损。
临床怎么用
- 作者认为保守治疗可能是上矢状窦血栓患者可行的治疗策略。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The safety and efficacy of anticoagulation in managing superior sagittal sinus (SSS) thrombosis remains unclear. The present study investigated the relationship between anticoagulation and cerebrovascular complications in parasagittal/parafalcine meningioma patients presenting with post-surgical SSS thrombosis. METHODS: We analyzed 266 patients treated at a single institution between 2005 and 2020. Bivariate analysis was conducted using the Mann-Whitney U test and Fisher's exact test. Multivariate analysis was conducted using a logistic regression model. Blood thinning medications investigated included aspirin, warfarin, heparin, apixaban, rivaroxaban, and other novel oral anticoagulants (NOACs). A symptomatic SSS thrombosis was defined as a radiographically apparent thrombosis with new headaches, seizures, altered sensorium, or neurological deficits. RESULTS: Our patient cohort was majority female (67.3%) with a mean age ([Formula: see text] SD) of 58.82 [Formula: see text] 13.04 years. A total of 15 (5.6%) patients developed postoperative SSS thrombosis and 5 (1.9%) were symptomatic; 2 (0.8%) symptomatic patients received anticoagulation. None of these 15 patients developed cerebrovascular complications following observation or anticoagulative treatment of asymptomatic SSS thrombosis. While incidence of any other postoperative complications was significantly associated with SSS thrombosis in bivariate analysis (p = 0.015), this association was no longer observed in multivariate analysis (OR = 2.15, p = 0.16) when controlling for patient age, sex, and anatomical location of the tumor along the SSS. CONCLUSIONS: Our single-institution study examining the incidence of SSS thrombosis and associated risk factors highlights the need for further research efforts better prognosticate this adverse outcome. Conservative management may represent a viable treatment strategy for patients with SSS thrombosis.
引用
- Jimenez AE, Khalafallah AM, Botros D, et al. The role of anticoagulation for superior sagittal sinus thrombosis following craniotomy for resection of parasagittal/parafalcine meningiomas. J Neurooncol. 2021. PMID: 34855096. doi:10.1007/s11060-021-03916-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。